Richard Bernstein Advisors LLC cut its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH – Free Report) by 60.0% during the 3rd quarter, HoldingsChannel reports. The fund owned 8,060 shares of the healthcare conglomerate’s stock after selling 12,100 shares during the quarter. Richard Bernstein Advisors LLC’s holdings in UnitedHealth Group were worth $2,783,000 at the end of the most recent reporting period.
A number of other large investors also recently added to or reduced their stakes in UNH. Winthrop Capital Management LLC purchased a new position in shares of UnitedHealth Group in the third quarter valued at about $860,000. Capital Research Global Investors grew its stake in shares of UnitedHealth Group by 126.9% in the third quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate’s stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares during the last quarter. Capital World Investors raised its position in UnitedHealth Group by 18.8% during the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate’s stock valued at $7,516,107,000 after purchasing an additional 3,439,182 shares during the last quarter. Capital International Inc. CA grew its position in shares of UnitedHealth Group by 47.8% in the 3rd quarter. Capital International Inc. CA now owns 394,934 shares of the healthcare conglomerate’s stock worth $136,371,000 after buying an additional 127,658 shares during the last quarter. Finally, Causeway Capital Management LLC bought a new position in shares of UnitedHealth Group during the third quarter valued at approximately $22,307,000. Hedge funds and other institutional investors own 87.86% of the company’s stock.
Analyst Ratings Changes
A number of research analysts have issued reports on UNH shares. Evercore raised shares of UnitedHealth Group to a “strong-buy” rating in a research report on Tuesday, January 6th. Leerink Partners cut their target price on shares of UnitedHealth Group from $410.00 to $345.00 and set an “outperform” rating on the stock in a research note on Wednesday, January 28th. Piper Sandler restated an “overweight” rating on shares of UnitedHealth Group in a report on Tuesday, January 27th. UBS Group reduced their target price on UnitedHealth Group from $430.00 to $410.00 and set a “buy” rating on the stock in a report on Wednesday, January 28th. Finally, Weiss Ratings cut UnitedHealth Group from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Monday, March 2nd. One investment analyst has rated the stock with a Strong Buy rating, seventeen have issued a Buy rating, eight have assigned a Hold rating and two have given a Sell rating to the stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $372.13.
UnitedHealth Group Stock Performance
Shares of UNH opened at $284.97 on Tuesday. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $606.36. The company has a quick ratio of 0.79, a current ratio of 0.79 and a debt-to-equity ratio of 0.72. The stock has a market cap of $258.67 billion, a P/E ratio of 21.61, a P/E/G ratio of 1.32 and a beta of 0.41. The business’s 50 day moving average price is $307.41 and its 200-day moving average price is $325.89.
UnitedHealth Group (NYSE:UNH – Get Free Report) last released its earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 EPS for the quarter, topping the consensus estimate of $2.09 by $0.02. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.The business had revenue of $113.73 billion for the quarter, compared to the consensus estimate of $113.38 billion. During the same period in the previous year, the company posted $6.81 earnings per share. The company’s revenue for the quarter was up 12.3% compared to the same quarter last year. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities research analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.
UnitedHealth Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th will be paid a dividend of $2.21 per share. This represents a $8.84 dividend on an annualized basis and a yield of 3.1%. The ex-dividend date is Monday, March 9th. UnitedHealth Group’s dividend payout ratio (DPR) is currently 67.02%.
UnitedHealth Group Profile
UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.
UnitedHealthcare is the company’s benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.
See Also
- Five stocks we like better than UnitedHealth Group
- Buy this Gold Stock Before May 15th, 2026
- The Market Just Split in Two (URGENT)
- Why did Buffett really step down?
- J.P. Morgan is betting on this coin
- Central banks just did something they haven’t done since 1967
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH – Free Report).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.
